Department of Rehabilitation, First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Department of Rehabilitation, First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
J Stroke Cerebrovasc Dis. 2023 Apr;32(4):106982. doi: 10.1016/j.jstrokecerebrovasdis.2023.106982. Epub 2023 Feb 4.
To evaluate the effect of non-invasive brain stimulation (NIBS) in improving limb motor dysfunction and daily living activity during at the phase of acute stroke.
Randomized controlled trials about the effect of NIBS on hemiparesis in acute stroke were retrieved from databases of China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang Data, CBM, PubMed, Embase, Cochrane Library, and Web of Science from inception until January 3rd 2022. The quality of the trials was assessed, and the data were extracted according to the Cochrane Handbook for Systematic Reviews of Interventions. A statistical analysis was carried out using Review Manager 5.3 and STATA 14. The effect size was evaluated by using the weighed mean difference (WMD) and a 95% confidence interval (CI). The stability and sensitivity of the results and sources of heterogeneity were also analyzed.
12 studies involving 639 patients were included. Our meta-analysis showed that NIBS could improve the Fugl-Meyer Assessment (weighed mean difference = 3.96, 95% confidence interval = 3.45 to 4.48) and Barthel Index (weighed mean difference = 12.29, 95% confidence interval = 4.93 to 19.66), while reducing the National Institutes of Health Stroke Scale (weighed mean difference = -2.37, 95% confidence interval = -3.43 to -1.31).
NIBS is effective in improving paretic limb motor function and activities of daily living in patients during at the phase of acute stroke.
评价非侵入性脑刺激(NIBS)在改善急性脑卒中患者肢体运动功能和日常生活活动方面的作用。
从中国知网(CNKI)、中国科技期刊数据库(VIP)、万方数据、CBM、PubMed、Embase、Cochrane 图书馆和 Web of Science 数据库中检索到 2022 年 1 月 3 日以前关于 NIBS 对急性脑卒中偏瘫影响的随机对照试验。按照 Cochrane 系统评价手册评价试验质量,并提取数据。使用 Review Manager 5.3 和 STATA 14 进行统计分析。采用加权均数差(WMD)和 95%置信区间(CI)评估效应量。分析结果的稳定性和敏感性以及异质性来源。
纳入 12 项研究共 639 例患者。Meta 分析结果显示,NIBS 可改善 Fugl-Meyer 评估(加权均数差=3.96,95%置信区间=3.45 至 4.48)和 Barthel 指数(加权均数差=12.29,95%置信区间=4.93 至 19.66),降低国立卫生研究院卒中量表评分(加权均数差=-2.37,95%置信区间=-3.43 至-1.31)。
NIBS 可有效改善急性脑卒中患者瘫痪肢体运动功能和日常生活活动能力。